The Institute of Cancer Research joins the Elekta and Philips research consortium to develop MRI-guided therapy system for cancer treatment

Home logo_363x90 Healthcare The Institute of Cancer Research joins the Elekta and Philips research consortium to develop MRI-guided therapy system for cancer treatment

The Institute of Cancer Research joins the Elekta and Philips research consortium to develop MRI-guided therapy system for cancer treatment

London, UK – Elekta (NSE:EKTAb) and Royal Philips (NYSE:PHG, AEX:PHIA) announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.

/ Healthcare / Tags: ,

Share the Post

About the Author

Philips Respironics

Philips Respironics, a global leader in the sleep and respiratory markets, is passionate about providing solutions that lead to healthier patients, healthier practices, and healthier businesses. For us, innovation is driven by gaining insight into the needs of the people who use our products in the areas of sleep apnea management, oxygen therapy, noninvasive ventilation and respiratory drug delivery.